Switching benefits and costs in the Irish health insurance market: an analysis of consumer surveys

International Journal of Health Economics and Management
Conor KeeganSteve Thomas

Abstract

Relatively little analysis has taken place internationally on the consumer-reported benefits and costs to switching insurer in multi-payer health insurance markets. Ideally, consumers should be willing to switch out of consideration for price and quality and switching should be able to take place without incurring significant switching costs. Costs to switching come in many forms and understanding the nature of these costs is necessary if policy interventions to improve market competition are to be successful. This study utilises data from consumer surveys of the Irish health insurance market collected between 2009 and 2013 (N [Formula: see text] 1703) to examine consumer-reported benefits and costs to switching insurer. Probit regression models are specified to examine the relationship between consumer characteristics and reported switching costs, and switching behaviour, respectively. Overall evidence suggests that switchers in the Irish market mainly did so out of consideration for price. Transaction cost was the most common switching cost identified, reported by just under 1 in 7 non-switchers. Psychological switching costs may also be impacting behaviour. Moreover, high-risk individuals were more likely to experience switc...Continue Reading

References

Mar 8, 1997·Journal of Health Economics·T C Buchmueller, P J Feldstein
May 17, 2000·Health Affairs·P J Cunningham, L Kohn
Dec 12, 2002·Journal of Health Economics·Frederik T Schut, Wolter H J Hassink
Dec 12, 2002·Journal of Health Economics·Gerard J Wedig, Ming Tai-Seale
Sep 9, 2004·Journal of Health Economics·Anthony T Lo Sasso, Thomas C Buchmueller
May 20, 2005·Applied Health Economics and Health Policy·Trea Laske-AldershofCarine Van de Voorde
Jun 9, 2005·Health Economics·Robert Nuscheler, Thomas Knaus
Dec 16, 2005·Inquiry : a Journal of Medical Care Organization, Provision and Financing·Adam AtherlyKenneth E Thorpe
Jul 19, 2008·Health Economics, Policy, and Law·Amir ShmueliLeah Achdut
Sep 16, 2008·National Bureau of Economic Research Bulletin on Aging and Health
Oct 7, 2008·Medical Care Research and Review : MCRR·Janet R CummingsYaniv Hanoch
Nov 26, 2008·Medical Care Research and Review : MCRR·Jonathan T Kolstad, Michael E Chernew
Jun 3, 2009·Health Services Research·Yaniv HanochStacey Wood
Mar 17, 2010·Medical Decision Making : an International Journal of the Society for Medical Decision Making·M Kate Bundorf, Helena Szrek
May 19, 2010·Health Economics, Policy, and Law·Gwyn Bevan, Wynand P M M van de Ven
Jul 20, 2010·Health Care Analysis : HCA : Journal of Health Philosophy and Policy·Christiaan J LakoChris Daw
Oct 30, 2010·Health Services Research·Lieke H H M BoonenFrederik T Schut
May 17, 2011·BMC Health Services Research·Margreet Reitsma-van RooijenMieke Rijken
Mar 29, 2012·The Quarterly Journal of Economics·Jeffrey R KlingMarian V Wrobel
Jun 22, 2012·Health Economics, Policy, and Law·Brian Turner, Edward Shinnick
Feb 12, 2013·Health Policy·Sarah ThomsonCarine Van de Voorde
Feb 19, 2013·International Journal of Health Care Finance and Economics·Conor KeeganConceição Portela
Jun 21, 2013·International Journal of Environmental Research and Public Health·Miriam Krieger, Stefan Felder
Nov 7, 2013·Journal of Health Politics, Policy and Law·Pamela Nadash, Rosemarie Day
Nov 12, 2014·Health Economics Review·Karolin Leukert-Becker, Peter Zweifel
Mar 31, 2015·The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care·Lieke H H M BoonenFrederik T Schut
Jul 16, 2015·Health Economics, Policy, and Law·Daniëlle M I D Duijmelinck, Wynand P M M van de Ven
Sep 12, 2015·The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care·Conor KeeganSteve Thomas
Feb 23, 2019·Inquiry : a Journal of Medical Care Organization, Provision and Financing·Michael R CousineauJoel Milam

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care
Conor KeeganSteve Thomas
National Bureau of Economic Research Bulletin on Aging and Health
Law and Contemporary Problems
M V Pauly
© 2022 Meta ULC. All rights reserved